Literature DB >> 19127428

Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer.

Mary A Bewick, Michael S C Conlon, Robert M Lafrenie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19127428     DOI： 10.1007/s10549-008-0293-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  1 in total

1.  A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.

Authors:  Petra Seibold; Peter Schmezer; Sabine Behrens; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Dieter Flesch-Janys; Heli Nevanlinna; Rainer Fagerholm; Kristiina Aittomäki; Carl Blomqvist; Sara Margolin; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Diether Lambrechts; Hans Wildiers; Vessela Kristensen; Grethe Grenaker Alnæs; Silje Nord; Anne-Lise Borresen-Dale; Maartje J Hooning; Antoinette Hollestelle; Agnes Jager; Caroline Seynaeve; Jingmei Li; Jianjun Liu; Keith Humphreys; Alison M Dunning; Valerie Rhenius; Mitul Shah; Maria Kabisch; Diana Torres; Hans-Ulrich Ulmer; Ute Hamann; Joellen M Schildkraut; Kristen S Purrington; Fergus J Couch; Per Hall; Paul Pharoah; Doug F Easton; Marjanka K Schmidt; Jenny Chang-Claude; Odilia Popanda
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.